Suping Ling
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
-
- Heart Failure Treatment and Management
Papers in
-
- Diabetes Treatment and Management 5
- Diabetes, Cardiovascular Risks, and Lipoproteins 2
- Diabetes Management and Research 2
- Oncology 4
- Global Cancer Incidence and Screening 3
- Co-authors
- Kamlesh Khunti (17 shared papers)Francesco Zaccardi (17 shared papers)Melanie Jane Davies (12 shared papers)Karen Brown (5 shared papers)Eyad Issa (4 shared papers)Thomas E. Yates (3 shared papers)Amy Morrison (2 shared papers)Lynne M. Howells (3 shared papers)
- Journals
- Diabetes Care (5 papers)Diabetes Obesity and Metabolism (3 papers)Diabetologia (2 papers)BMC Cancer (1 paper)Journal of Diabetes Investigation (1 paper)
- Partner nations
- United KingdomChinaUnited States
In The Last Decade
Suping Ling
20 papers receiving 506 citations
Peers
Comparison fields: 5 of 64
- Endocrinology, Diabetes and Metabolism 130
- Cardiology and Cardiovascular Medicine 123
- Oncology 91
- Drug Discovery 1
- Molecular Biology 150
Countries citing papers authored by Suping Ling
This map shows the geographic impact of Suping Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suping Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suping Ling more than expected).
Fields of papers citing papers by Suping Ling
This network shows the impact of papers produced by Suping Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suping Ling. The network helps show where Suping Ling may publish in the future.
Co-authors
The 25 scholars most cited alongside Suping Ling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 176 | |
| 2 | 2019 | 128 | |
| 3 | 2020 | 55 | |
| 4 | 2023 | 41 | |
| 5 | 2020 | 29 | |
| 6 | 2021 | 27 | |
| 7 | 2020 | 24 | |
| 8 | 2020 | 10 | |
| 9 | 2022 | 7 | |
| 10 | 2022 | 6 | |
| 11 | 2023 | 6 | |
| 12 | 2023 | 3 | |
| 13 | 2025 | 3 | |
| 14 | 2023 | 2 | |
| 15 | 2025 | 2 | |
| 16 | 2020 | 1 | |
| 17 | 2020 | 1 | |
| 18 | 2023 | 1 | |
| 19 | 2025 | 1 | |
| 20 | 2025 | 1 |
About Suping Ling
Suping Ling is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology, Molecular Biology, Geriatrics and Gerontology and Physical Therapy, Sports Therapy and Rehabilitation, having authored 21 papers that have together received 524 indexed citations. Recurring topics across this work include Metabolism, Diabetes, and Cancer (8 papers), Diabetes Treatment and Management (5 papers), Global Cancer Incidence and Screening (3 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers), Diabetes Management and Research (2 papers), Down syndrome and intellectual disability research (1 paper), Cancer, Hypoxia, and Metabolism (1 paper) and Economic and Financial Impacts of Cancer (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (130 citations), Cardiology and Cardiovascular Medicine (123 citations), Oncology (91 citations), Drug Discovery (1 citation) and Molecular Biology (150 citations). Suping Ling has collaborated with scholars based in United Kingdom, China and United States. Frequent co-authors include Kamlesh Khunti, Francesco Zaccardi, Melanie Jane Davies, Karen Brown, Eyad Issa, Thomas E. Yates, Amy Morrison, Lynne M. Howells, Joanne K. Miksza and Claire Alexandra Lawson. Their work appears in journals such as Diabetes Care, Diabetes Obesity and Metabolism, Diabetologia, BMC Cancer and Journal of Diabetes Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.